Commission Implementing Decision of 22 November 2013 on setting up the Biobanks and Biomolecular Resources Research Infrastructure Consortium (BBMRI-ERIC) as a European Research Infrastructure Consortium (2013/701/EU)

Article 1 U.K. Definitions

For the purpose of these Statutes:

(1)

‘Biobanks (and Biomolecular Resources Centres)’ means collections, repositories and distribution centres of all types of human biological samples, such as blood, tissues, cells or DNA and/or related data such as associated clinical and research data, as well as biomolecular resources, including model- and micro-organisms that might contribute to the understanding of the physiology and diseases of humans;

(2)

‘Member’ means an entity according to Article 4(1);

(3)

‘Observer’ means an entity according to Article 4(7);

(4)

‘Defaulting Member’ means a Member, which

(a)

is in default of the payment of its annual contribution, if the outstanding amount equals or exceeds the amount of contributions due for the preceding financial year;

(b)

seriously fails in its obligations; or

(c)

causes or threatens to cause serious disruption in the operation of BBMRI-ERIC;

(5)

‘Common Service’ means a facility of BBMRI-ERIC according to Article 15(1);

(6)

‘National Node’ means an entity, not necessarily with legal capacity, designated by a Member State, that coordinates the national Biobanks and Biomolecular Resources, and links its activities with the pan-European activities of BBMRI-ERIC;

(7)

‘National Coordinator’ means the director of a National Node, appointed by the competent authority of a Member State;

(8)

‘Organisational Node’ means an entity, not necessarily with legal capacity, designated by an intergovernmental organisation that coordinates the Biobank(s) and Biomolecular Resources of the organisation, and links its activities with those of the pan-European infrastructure, BBMRI-ERIC;

(9)

‘Organisational Coordinator’ means the director of an Organisational Node, appointed by an intergovernmental organisation;

(10)

‘Partner Biobanks’ means Biobanks collaborating with BBMRI-ERIC that comply with the BBMRI-ERIC Partner Charter(1);

(11)

‘Work Programme’ means the description of the strategy, planned activities, staffing and funding of BBMRI-ERIC;

(12)

‘Mandatory contributions’ mean the contributions by Members/Observers and the contributions by the hosting countries for the Central Executive Management Office as well as for Common Services which are laid down within the budget section of the BBMRI-ERIC annual Work Programme.

(1)

To be adopted by the Assembly of Members.